A humorous, cinematic cruise ship sailing through choppy Wall Street waters. On deck, a private-equity titan in a blazer holds a giant $25 million boarding pass, a fast-food executive captain wears a Burger King/Subway-style crown-and-captain hat

🚢 Norwegian Cruise Line (NCLH): Why Insiders Just Bought $27M of Stock

Norwegian Cruise Line Holdings may be more than a cruise recovery stock. With a new CEO, nearly $27 million in insider purchases, institutional ownership locking up almost the entire float, and valuation metrics that look surprisingly cheap, NCLH is turning into one of the more intriguing turnaround stories on deck.

Read entire article

🧬 Annexon, Part 2: The $300,000 Guillain-Barré Cost Matrix and the Pipeline Fuse

Delve into the high-stakes financial and clinical reality of Guillain-Barré Syndrome (GBS)—a devastating neurological emergency carrying a brutal $300,000 cost of standard care. In Part 2 of our Annexon Biosciences (NASDAQ: ANNX) deep dive, we audit how their lead late-stage asset, Tanruprubart, targets C1q neuroinflammation at the source to completely upend healthcare economics, transform patient outcomes, and detonate an 11-day short squeeze trap.

Read entire article

A futuristic city powered by artificial intelligence, with glowing data highways connecting global enterprises. A tollbooth labeled

🌐 Globant (GLOB): The AI Infrastructure Tollbooth Trading at 7x Earnings

Globant (NYSE: GLOB) may be one of the most intriguing AI-related value plays on the market. Trading 87% below its peak, the company combines a growing AI-native services platform, accelerating cash flow, aggressive share buybacks, institutional ownership above 100% of float, and a historic first insider purchase from former Hong Kong Exchange CEO Alejandro Aguzin. Is Wall Street missing the story?

 

Read entire article

Cartoon-style illustration of a confident goose in a business suit representing Goosehead Insurance, standing in a digital insurance command center with AI robots, insurance policies, storm clouds, Wall Street institutions, and worried short sellers.

🪶 Goosehead Insurance (GSHD): The C-Suite Double-Down on a Deeply Plucked Stock

Goosehead Insurance has been deeply plucked, but insiders are buying the dip while Q1 adjusted EBITDA surged 57%. With a tech-enabled, asset-light broker model, institutional ownership above the float, and short interest near 8%, GSHD offers a risky but fascinating GARP setup.

Read entire article

Illustration of a digital tollbooth standing on the Information Superhighway. Businesses, schools, and government agencies drive cloud servers, laptops, and AI robots through the toll plaza while CDW operators collect technology tolls.

🖥️ CDW Corporation (CDW): The Tech Infrastructure Tollbooth Trading at an Uncharacteristic Discount

CDW Corporation may not build AI chips, but it helps organizations deploy the technology revolution. With insider buying, strong earnings, a growing buyback program, and a forward P/E of just 11.2x, this tech infrastructure giant could be trading at one of its most attractive valuations in years.

Read entire article

Illustration of a trillion-dollar private markets highway with Hamilton Lane operating a glowing toll booth as institutional investors and wealth advisors stream through, symbolizing the firm's role as a high-margin gatekeeper to global private markets.

📈 Hamilton Lane (HLNE): The Toll Booth on a Trillion-Dollar Private Markets Highway

Hamilton Lane (HLNE) may be one of the most attractive alternative asset managers on the market today. Massive insider buying, a growing dividend, a trillion-dollar asset footprint, and expanding private-wealth opportunities combine to create a compelling long-term investment story.

Read entire article

Illustration of futuristic Celsius energy drink cans glowing with electric neon colors inside a high-performance trading floor and fitness environment hybrid, surrounded by rising stock charts, athletes, institutional investors, and explosive energy waves

⚡ Celsius Holdings (CELH): Wall Street Panicked. Insiders Bought the Dip

Celsius Holdings (CELH) may no longer be just a trendy fitness energy drink brand. With explosive 138% revenue growth, synchronized insider buying, Alani Nu integration success, and PepsiCo’s distribution engine accelerating expansion, the stock increasingly looks like a high-growth GARP opportunity hiding beneath a brutal valuation reset.

Read entire article

Cartoon-style image of Flutter Entertainment as a giant Wall Street casino, with executives placing huge bets on FLUT stock while poker chips, sportsbook screens, and institutional investors dominate the scene.

🎲 Flutter Entertainment (FLUT): Betting on the House at a 12x Discount

Flutter Entertainment (FLUT) has collapsed 69% from its highs, yet insiders are aggressively buying shares while FanDuel continues dominating U.S. sports betting. Is Wall Street underpricing one of the world’s most powerful gambling platforms?

Read entire article

Cinematic illustration of Boston Scientific as a futuristic medtech powerhouse, with glowing cardiovascular devices, a heart-shaped stock chart, doctors, investors, and a $2B buyback shield symbolizing healthcare innovation and a GARP stock opportunity.

🫀 Boston Scientific (BSX): A GARP Reset on a Medical Device Powerhouse

Boston Scientific stock has fallen nearly 48% from its highs, but the business engine remains strong. With double-digit revenue growth, major cardiovascular catalysts, director insider buying, low short interest, and a $2B buyback, BSX may be one of the cleaner large-cap healthcare GARP setups on the market.

Read entire article

Futuristic illustration of HubSpot as an AI-powered CRM command center, with glowing marketing funnels, customer icons, Breeze AI agents, insider buyers, stock charts, and a HUBS rocket symbolizing the debate between valuation fear and growth opportunity.

🏗️ HubSpot (HUBS): From “Hubris” to “Hand-over-Fist”?

HubSpot (HUBS) just delivered strong Q1 2026 results, but the stock still plunged as investors questioned AI monetization, sales cycles, and valuation. With the CEO, founder-CTO, and director buying shares, institutions owning the float, revenue growing 23%, and valuation metrics finally looking reasonable, HUBS may be shifting from “growth at any price” to a serious GARP contender. 🏗️🤖📈

Read entire article